pentobarbital will reduce the level or effect of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with potent CYP3A4 inducers can lead to decreased serum concentrations and lack of antimalarial efficacyIn patients with hepatic damage, barbiturates really should be administered with caution a